These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10709461)

  • 1. [Design of human liposomal recombinant alpha2-interferon-containing preparation].
    Zolin VV; Kolokol'tsov AA; Agafonova OA; Bochkova TG
    Vestn Ross Akad Med Nauk; 1999; (12):18-22. PubMed ID: 10709461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Methodological approaches to creating a liposomal form of human recombinant alpha 2-interferon].
    Zolin VV; Luk'ianov AN; Nesterov AE; Kolokol'tsov AA; Torchilin VP; Popov VF; Vardanian NV; Antonov NA
    Vestn Ross Akad Med Nauk; 1993; (2):29-31. PubMed ID: 7688615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of experimental genital herpes with liposomal interferon].
    Mel'nikov VR; Kobrinskiĭ GD; L'vov ND; Bolotin IM; Barinskiĭ IF
    Vestn Akad Med Nauk SSSR; 1990; (8):35-7. PubMed ID: 2275275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Indices of circulating interferon in different viral diseases].
    Lavrukhina LA; Ershov FI; Krylov VF; Kniazeva LD; Belostotskaia OI
    Vopr Virusol; 1989; 34(2):244-7. PubMed ID: 2474908
    [No Abstract]   [Full Text] [Related]  

  • 5. [Interactions of interferon with other immunomodulators in the regulation of human natural killer cell activity].
    Cheknev SB; Latysheva OL; Denisov LA; Ershov FI
    Biull Eksp Biol Med; 1992 Feb; 113(2):179-82. PubMed ID: 1377045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biological activity of human alpha-interferons studied using specific antisera].
    Korsun NS; Nosik DN; Novokhatskiĭ AS; Trushinskaia GN
    Antibiot Khimioter; 1988 Nov; 33(11):827-30. PubMed ID: 2465745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of experimental genital herpes with liposomal interferon.
    Kobrinskii GD; Mel'nikov VR; Kulakov VN; L'vov ND; Bolotin IM; Barinskii IF
    Biomed Sci; 1991; 2(1):29-32. PubMed ID: 1912245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activation of phagocytosis by preparations of human alpha and gamma interferons].
    Vakhrameeva NS; Avdeeva ZhE; Kuznetsov VP; Bobkova EV; Krylov OR
    Vopr Virusol; 1988; 33(2):181-4. PubMed ID: 3137727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The immunomodulating action of interferons in their combined use with a typhus vaccine].
    Malinkin IuN; Mikhaĭlov VV; Pshenichnov VA; Pashanina TP
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (5):65-71. PubMed ID: 8067148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of interferon-consensus 1, interferon-alpha 2a, and interferon-beta 1b on HLA expression and lymphoproliferation: a preclinical model for treatment of multiple sclerosis.
    Dhib-Jalbut S; Jiang H; Xia Q; Blatt L; Johnson KP; Hilt D
    J Interferon Cytokine Res; 1996 Mar; 16(3):195-200. PubMed ID: 8697141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of interferons alpha, beta, and gamma against human immunodeficiency virus replication in vitro.
    Hartshorn KL; Neumeyer D; Vogt MW; Schooley RT; Hirsch MS
    AIDS Res Hum Retroviruses; 1987; 3(2):125-33. PubMed ID: 3113463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of recent developments in the molecular characterization of recombinant alfa interferons on the 40th anniversary of the discovery of interferon.
    Walter MR; Bordens R; Nagabhushan TL; Williams BR; Herberman RB; Dinarello CA; Borden EC; Trotta PP; Pestka S; Pfeffer LM
    Cancer Biother Radiopharm; 1998 Jun; 13(3):143-54. PubMed ID: 10850350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Liposome-incorporated interferon. The design of liposomal interferon].
    Kalenik TN; Motavkina NS; Vorob'ev AA
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (3):55-8. PubMed ID: 10851992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The combined treatment of experimental genital herpes with preparations of interferon and acycloguanosine administered systemically and locally].
    Mel'nikov VR; Kobrinskiĭ GD; Lidak MIu; Barinskiĭ IF
    Vopr Virusol; 1993; 38(2):69-71. PubMed ID: 8059524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the influence of liposomal lipid composition on liposome size, zeta potential and liposome-induced dendritic cell maturation using a design of experiments approach.
    Soema PC; Willems GJ; Jiskoot W; Amorij JP; Kersten GF
    Eur J Pharm Biopharm; 2015 Aug; 94():427-35. PubMed ID: 26144666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systemic analysis of neuroimmune mechanisms of memory].
    Zhuravlev BV; Murtazina EP; Sulin VIu
    Ross Fiziol Zh Im I M Sechenova; 1997; 83(11-12):19-28. PubMed ID: 9541953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results and prospects of using interferon preparations in the treatment of infections in pediatric practice].
    Malinovskaia VV; Ershov FI
    Vestn Akad Med Nauk SSSR; 1990; (7):32-6. PubMed ID: 2120860
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of antiinfectious potential of recombinant tumor necrosis factor-alpha].
    Kalinin IuT; Pustoshilova NM; Denisov LA; Afanas'ev SS; Marchenko VI; Vorob'ev AA; Rubal'skiĭ OV; Shcherbakov GIa
    Vestn Ross Akad Med Nauk; 1998; (10):29-32. PubMed ID: 9846109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities.
    Ozes ON; Reiter Z; Klein S; Blatt LM; Taylor MW
    J Interferon Res; 1992 Feb; 12(1):55-9. PubMed ID: 1573283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antitoxic activity of interferon preparations].
    Zueva VS; Pashutin SB; Kuznetsov VP; Spivak NIa; Korobko IV
    Antibiot Med Biotekhnol; 1985 Sep; 30(9):665-8. PubMed ID: 2415059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.